This study aimed to verify the hypothesis that ANXA1 (Ac2-26) inhibits inflammation and apoptosis through the Fpr2 receptor to alleviate sepsis-induced AKI and explore its underlying mechanism. Here, ANXA1 is linked to Sepsis.